血栓长度预测轻型卒中大血管闭塞溶栓后早期未再通
本研究基于法国多中心登记数据,纳入97例NIHSS≤5的大血管闭塞轻型卒中患者,评估静脉溶栓后早期再通情况。结果显示34%患者实现早期再通,血栓长度是未再通的唯一独立预测因素(每增加1mm OR 1.53,95%CI 1.21-1.92,P<0.001),最佳截断值9mm,C统计量0.82。
要点
- 轻型卒中大血管闭塞溶栓后早期再通率约34%。
- 血栓长度每增加1mm,未再通风险增加53%(OR 1.53)。
- 血栓长度≥9mm预测未再通敏感性67.8%、特异性84.6%。
核心结论
- 在考虑取栓的静脉溶栓治疗轻型卒中大血管闭塞患者中,早期再通常见,血栓长度是未再通的强独立预测因素。
研究设计与样本
- 研究从2015至2017年法国多中心大血管闭塞取栓登记中提取97例轻型卒中(NIHSS≤5)患者,均在溶栓开始后3小时内通过首次血管造影或无创影像评估早期再通。
主要发现
- 中位NIHSS为3(四分位距2-4),闭塞部位近端(颅内颈动脉或M1)和远端(M2)各占50%。
- 溶栓前MRI上90%可见磁敏感血管征,中位长度为9.2mm(四分位距7.4-13.3)。
- 早期再通率为34%,磁敏感血管征长度是唯一与未再通相关的临床或影像变量(每增加1mm OR 1.53,95%CI 1.21-1.92,P<0.001)。
关键数值与推荐
- 磁敏感血管征长度预测未再通的C统计量为0.82(95%CI 0.73-0.92),最佳截断值(Youden)为9mm。
- 该截断值预测未再通的敏感性为67.8%(95%CI 55.9-79.7),特异性为84.6%(95%CI 70.7-98.5)。
临床怎么用
- 对于轻型卒中大血管闭塞患者,测量血栓长度(磁敏感血管征)有助于识别静脉溶栓后早期再通可能性低者,可能辅助筛选适合桥接治疗随机试验的候选者。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Whether bridging therapy, that is, intravenous thrombolysis [IVT] followed by mechanical thrombectomy, is beneficial as compared with IVT alone in minor stroke (National Institutes of Health Stroke Scale ≤5) with large vessel occlusion is unknown and should be tested in randomized trials. To help select the most appropriate candidates for such trials, we aimed to identify strong predictors of lack of post-IVT early recanalization (ER)-a surrogate marker of poor outcome. Methods- From a large multicenter French registry of patients with large vessel occlusion referred for thrombectomy immediately after IVT start between 2015 and 2017, we extracted 97 minor strokes with ER evaluated on first angiographic run or noninvasive imaging ≤3 hours from IVT start. Thrombus length was measured using the susceptibility vessel sign on T2* imaging. Results- Median National Institutes of Health Stroke Scale was 3 (interquartile range, 2-4), and occlusion sites were proximal (intracranial carotid or M1) and distal (M2) in 50% and 50% of patients, respectively. On pre-IVT MRI, median length of susceptibility vessel sign (visible in 90%) was 9.2 mm (interquartile range, 7.4-13.3). ER was present in 34% of patients, and susceptibility vessel sign length was the only clinical or radiological variable associated with no-ER after stepwise variable selection into a multivariable model (odds ratio, 1.53 per 1-mm increase; 95% CI, 1.21-1.92; P<0.001). The C statistic of susceptibility vessel sign length for no-ER prediction was 0.82 (95% CI, 0.73-0.92), and the optimal cutoff (Youden) was 9 mm. Sensitivity and specificity of this cutoff for no-ER were 67.8% (95% CI, 55.9-79.7) and 84.6% (95% CI, 70.7-98.5), respectively. Conclusions- ER was frequent in this cohort of IVT-treated minor stroke patients with large vessel occlusion considered for thrombectomy, and thrombus length was a powerful independent predictor of no-ER. These findings may help design randomized trials aiming to test bridging therapy versus IVT alone in this population.
引用
- Seners P, Delepierre J, Turc G, et al. Thrombus Length Predicts Lack of Post-Thrombolysis Early Recanalization in Minor Stroke With Large Vessel Occlusion. Stroke. 2019. PMID: 30802186. doi:10.1161/STROKEAHA.118.023455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。